drugset / Trial / NCT03504735
Caduet and TLC Intervention in Metabolic Syndrome
Phase 4
Completed
53 enrolled
The University of Texas Medical Branch, Galveston
Pfizer · collabUniversity of Texas Southwestern Medical Center · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the effectiveness of Caduet in addition to therapeutic life-style change (TLC) intervention in resolving metabolic syndrome fifty three individuals were randomized to TLC intervention study with or without Caduet therapy for 12 months. The participants underwent monthly visits with investigators to obtain vital signs, and to undergo TLC counseling. Metabolic parameters were measured before and after intervention.
Timeline
- Start
- 2005-05-01
- Primary completion
- 2009-01-01
- Completion
- 2016-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Caduet | Unknown | — | — |